EXEL SP | EXEL Message Board Posts

EXEL   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  21658 of 22110  at  3/13/2019 6:05:02 PM  by

cuckoolefou


 In response to msg 21655 by  hbomb57108
view thread

Re: EXEL SP

Good point that the large benefit could be the result of luck, and that repeat trials could be more modest in result. It's interesting to me that Morrissey responds so casually that 9er could well be better. One would expect this if you assume pembro And nivo are roughly the same. Which is not certain of course, but would be my best guess. I think that probably anti Pd1>pd-L1 though. Just a guess.

One other thing is that Merck seems to be better than BMY in designing their trials. That is my impression, but maybe it is that pembro>Nivo after all.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 277
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...